RecruitingNot ApplicableNCT07166133
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
Sponsor
W.L.Gore & Associates
Enrollment
125 participants
Start Date
Mar 2, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called GORE® TAG® Thoracic Branch Endoprosthesis for people with aortic arch aneurysm and aortic arch dissection. The study is currently recruiting participants at 7 locations. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEGORE® TAG® Thoracic Branch Endoprosthesis
Lesions in aortic arch in Zone 0 or Zone 1
Locations(12)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07166133
Related Trials
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
NCT0708957621 locations
Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms
NCT015242111 location
European Aortic Data Collection Project
NCT0589639718 locations
Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study)
NCT0638537920 locations
CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft
NCT020896073 locations